Redefining Cirrhotic Cardiomyopathy for the Modern Era

Manhal Izzy, Lisa B. VanWagner, Grace Lin, Mario Altieri, James Y. Findlay, Jae K. Oh, Kymberly D. Watt, Samuel S. Lee, on behalf of The Cirrhotic Cardiomyopathy Consortium – 25 July 2019 – Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in patients with end‐stage liver disease in the absence of prior heart disease. First defined in 2005 during the World Congress of Gastroenterology, CCM criteria consisted of echocardiographic parameters to identify subclinical cardiac dysfunction in the absence of overt structural abnormalities.

Reply

Florence Wong, K. Rajender Reddy, Jacqueline G. O’Leary, Guadalupe Garcia‐Tsao, Patrick S. Kamath, Jasmohan S. Bajaj, for the North American Consortium for the Study of the Liver – 25 July 2019

The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation

Samarth S. Patel, Viviana A. Rodriguez, Mohammad B. Siddiqui, Masoud Faridnia, Fei‐Pi Lin, Anchalia Chandrakumaran, John Laurenzano, Joseph Clinton, Gurukripa N. Kowlgi, Danielle Kirkman, Adam P. Sima, Erika Liptrap, Chandra Bhati, Mohammad Shadab Siddiqui – 25 July 2019 – Cardiovascular disease (CVD) is a major contributor to longterm mortality after liver transplantation (LT) necessitating aggressive modification of CVD risk.

Liver Imaging Reporting and Data System Version 2018: Impact on Categorization and Hepatocellular Carcinoma Staging

Victoria Chernyak, Milana Flusberg, Jesse Berman, Kate C. Fruitman, Mariya Kobi, Kathryn J. Fowler, Claude B. Sirlin – 25 July 2019 – The purpose of this study was to assess the concordance in categorization and radiologic T staging using Liver Imaging Reporting and Data System (LI‐RADS, LR) version 2017 (v2017), version 2018 (v2018), and the Organ Procurement and Transplantation Network (OPTN) criteria. All magnetic resonance imaging and computed tomography reports using a standardized LI‐RADS macro between April 2015 and March 2018 were identified retrospectively.

Subscribe to